The inhibition countercurrent immunoelectrophoresis test was employed to detect dengue virus antibody in patients' sera. Anti-dengue type 2 titers determined by inhibition countercurrent immunoelectrophoresis correlated well with hemagglutination inhibition titers. In secondary cases, more than fourfold increases in precipitating antibodies were observed. The control sera were negative except for sera from a few patients with systemic lupus erythematosus, which showed low titers. Simultaneous detection of dengue virus antigen and antibody in sera collected during the acute phase could confirm at least 90% of cases. This method is recommended as a routine technique to quantitate antibody in sera from suspected cases of dengue hemorrhagic fever.
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The hemagglutination inhibition (HI) test described by Clarke and Casals (6) is the most common serological technique used for the diagnosis of dengue hemorrhagic fever (DHF). Other diagnostic procedures are the complement fixation test (11) , the virus neutralization test (15) , and virus isolation from patients' sera (8, 14) . Immunofluorescence techniques have also been applied to determine titers of dengue antibody in patients' sera (2) .
Countercurrent immunoelectrophoresis has been widely used recently to detect hepatitis B surface antigen (HGsAg) (7), adenoviruses (9), influenza virus antibody (1), California group arboviruses (10) , and dengue antigens in sera of DHF patients (4, 5) .
CIE is simple to perform and requires no elaborate equipment. The technique can be applied to the routine examination of a large number of blood specimens. To apply the CIE technique for the determination of dengue antibodies in sera of DHF patients, the method of inhibition countercurrent immunoelectrophoresis (ICEP) described by Milner et al. (12) Results of HI and ICEP tests on acute-and convalescent-phase sera from 52 patients with secondary dengue infection are shown in Table  2 . Acute-phase sera with HI titers of lower than 1:640 showed negative ICEP titers (Fig. 1) . For acute-phase sera with HI titers of 1:5,120 and higher, ICEP titers were all positive. All convalescent-phase sera showed precipitating antibody by ICEP, with titers ranging from 1:8 to 1: 512 ( Fig. 2) (3) . Therefore, the detection of dengue antibody in these patients was in accordance with results reported by other investigators. Since ICEP was negative in sera from patients with known diseases other than dengue infection and in normal human sera, with the exception of some systemic lupus erythematosus patients, ICEP titers of 21:8 in acute-phase serum might be taken as evidence of dengue infection.
ICEP can be a practical test for routine laboratory use, since single or large numbers of specimens can be processed at a given time without much difference in time and expense. The HI test is a retrospective test, and paired sera are needed to make a diagnosis. Testing small numbers of specimens by HI is not practical or economical for most laboratories. Before the development of the ICEP test, physicians had to wait a long time for serodiagnosis of dengue infection, and after the patients had left the hospital by the time the diagnosis was confirmed. ICEP titers, which can be obtained in 1 day, could solve part of this problem. In our experience, a fourfold increase in the ICEP titer can be observed in only 2 to 3 days, which is quicker than increases in the HI titer and makes ICEP useful for rapid diagnosis.
Other advantages are the fact that extraction and absorption of test sera are not required for ICEP tests and that the antigen can be in a crude form instead of in the sucrose-acetoneextracted form needed for the HI test. Evaluation of the ICEP test confirms its value as one of the rapid diagnostic tests for DHF, especially from the standpoint of economy.
